NEW YORK , Oct. 25, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ: ACHC ).
Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980.
Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The class action concerns whether Acadia and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. You have until December 16, 2024 , to ask the Court to appoint you as Lead Plaintiff for the class if you are a shareholder who purchased or otherwise acquired Acadia securities during the Class Period.
A copy of the Complaint can be obtained a t www.pomerantzlaw.com .
[Click here for information about joining the class action] On Sunday, September 1, 2024 , The New York Times published an article entitled "How a Leading Chain of Psychiatric Hospitals Traps Patients." Citing "records reviewed by The Times", the article reported that "Acadia has lured patients into its facilities and held them against their will, even when detaining them was not medically necessary" and that "[i]n at least 12 of the 19 states where Acadia operates psychiatric hospitals, dozens of patients, employees and police officers have alerted the authorities that the company was detaining people in way.